Treatment of status epilepticus in adults: Guidelines of the Italian League against Epilepsy

Epilepsia

Volumn 47, Issue SUPPL. 5, 2006, Pages 9-15

  Minicucci, Fabio ^a   Muscas, Giancarlo ^b   Perucca, Emilio ^c   Capovilla, Giuseppe ^d   Vigevano, Federico ^e   Tinuper, Paolo ^f  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d CARLO POMA HOSPITAL   (Italy)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antiepileptic drugs; Epilepsy; Guidelines; Italian league against epilepsy; Status epilepticus; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE; DIAZEPAM; FOSPHENYTOIN SODIUM; GLUCOSE; ISOFLURANE; LIDOCAINE; LORAZEPAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PROPOFOL; THIAMINE; THIOPENTAL; VALPROIC ACID;

ADULT; ANTICONVULSANT THERAPY; BOLUS INJECTION; CLINICAL PRACTICE; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; EPILEPTIC STATE; HALLUCINATION; HEART ARRHYTHMIA; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; ITALY; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RISK; SEDATION; STEVENS JOHNSON SYNDROME;

ADULT; AGE FACTORS; ANESTHESIA, GENERAL; ANTICONVULSANTS; BENZODIAZEPINES; HUMANS; INTERNATIONAL AGENCIES; ITALY; LORAZEPAM; PHENOBARBITAL; PHENYTOIN; PRACTICE GUIDELINES; PROPOFOL; RECURRENCE; STATUS EPILEPTICUS; THIOPENTAL; VALPROIC ACID;

EID: 33845543071     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2006.00870.x     Document Type: Conference Paper

References (80)

1. ACEP Clinical Policies Committee, Clinical Policies Subcommittee on Seizures. (2004) Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with seizures. Annals of Emergency Medicine 43:605-625.
2. Aggarwal P, Wali JP. (1993) Lidocaine in refractory status epilepticus: a forgotten drug in the emergency department. American Journal of Emergency Medicine 11:243-244.
3. Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, Gottwald MD, O'Neil N, Neuhaus JM, Segal MR, Lowenstein DH. (2001) A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. New England Journal of Medicine 345:631-637.
4. Appleton R, Sweeney A, Choonara I, Robson J, Molyneux E. (1995) Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus. Developmental Medicine and Child Neurology 37:682-688.
5. Barry E, Hauser WA. (1994) Status epilepticus and antiepileptic medication levels. Neurology 44:47-50.
6. Browne TR. (1978) Drug therapy reviews: drug therapy of status epilepticus. American Journal of Hospital Pharmacy 35:915-922.
7. Calistri V, Caramia F, Bianco F, Fattapposta F, Pauri F, Bozzao L. (2003) Visualization of evolving status epilepticus with diffusion and perfusion MR imaging. American Journal of Neuroradiology 24:671-673.
8. Cereghino JJ, Mitchell WG, Murphy J, Kriel RL, Rosenfeld WE, Trevathan E. (1998) Treating repetitive seizures with a rectal diazepam formulation: a randomized study. The North American Diastat Study Group. Neurology 51:1274-1282.
9. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. (2002) Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 43:146-153.
10. Coeytaux A, Jallon P, Galobardes B, Morabia A. (2000) Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 55:693-697.
11. D'Agostino MD, Andermann F, Dubeau F, Fedi M, Bastos A. (1999) Exceptionally long absence status: multifactorial etiology, drug interaction and complications. Epileptic Disorders 1:229-232.
12. Delgado-Escueta AV, Wasterlain C, Treiman DM, Porter RJ. (1982) Current concepts in neurology: management of status epilepticus. New England Journal of Medicine 306:1337-1340.
13. DeLorenzo RJ, Towne AR, Pellock JM, Ko D. (1992) Status epilepticus in children, adults, and the elderly. Epilepsia 33(suppl. 4):S15-S25.
14. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. (1995) Epidemiology of status epilepticus. Journal of Clinical Neurophysiology 13:458.
15. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, Fortner CA, Ko D. (1996) A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46:1029-1035.
16. DeLorenzo RJ, Garnett LK, Towne AR, Waterhouse EJ, Boggs JG, Morton L, Choudhry MA, Barnes T, Ko D. (1999) Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia 40:164-169.
17. Dieckmann RA. (1994) Rectal diazepam for prehospital treatment on the outcome of status epilepticus in children. Pediatric Neurology 23:216-224.
18. Drislane F. (1999) Evidence against permanent neurologic damage from nonconvulsive status epilepticus. Journal of Clinical Neurophysiology 16:323-331.
19. Drislane FW, Schomer DL. (1994) Clinical implications of generalized electrographic status epilepticus. Epilepsy Research 19:111-121.
20. Dziewas R, Kellinghaus C, Ludemann P. (2002) Nonconvulsive status epilepticus in patients with juvenile myoclonic epilepsy: types and frequencies. Seizure 11:335-339.
21. Engel J Jr., Ludwig BI, Fetell M. (1978) Prolonged partial complex status epilepticus: EEG and behavioral observations. Neurology 28:863-869.
22. Epilepsy Foundation of America's Working Group on Status Epilepticus. (1993) Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. Journal of the American Medical Association 270:854-859.
23. Fischer JH, Patel TV, Fischer PA. (2003) Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clinical Pharmacokinetics 42:33-58.
24. Gastaut H. (1983) Classification of status epilepticus. Advances in Neurology 34:15-35.
25. Gordon IJ, Nisbet HI, Jones ES. (2000) Status epilepticus treated with a muscle relaxant: the first success. The Quarterly Journal of Medicine 93:837-838.
26. Hauser WA. (1990) Status epilepticus: epidemiologic considerations. Neurology 40(suppl. 2):9-13.
27. Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. (1998) Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 50:735-741.
28. Hilz MJ, Bauer J, Claus D, Stefan H, Neundorfer B. (1992) Isoflurane anesthesia in the treatment of convulsive status epilepticus. Case report. Journal of Neurology 239:135-137.
29. Holtkamp M, Masuhr F, Harms L, Einhaupl KM, Meierkord H, Buchheim K. (2003) The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists. Journal of Neurology, Neurosurgery and Psychiatry 74:1095-1099.
30. Holtkamp M, Othman J, Buchheim K, Meierkord H. (2005) Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. Journal of Neurology, Neurosurgery, and Psychiatry 76:534-539.
31. Hong KS, Cho YJ, Lee SK, Jeong SW, Kim WK, Oh EJ. (2004) Diffusion changes suggesting predominant vasogenic oedema during partial status epilepticus. Seizure 13:317-321.
32. Hui AC, Cheng C, Lam A, Mok V, Joynt GM. (2005) Prognosis following postanoxic myoclonus status epilepticus. European Neurology 54:10-13.
33. Igartua J, Silver P, Maytal J, Sagy M. (1999) Midazolam coma for refractory status epilepticus in children. Critical Care Medicine 27:1982-1985.
34. Jordan KG. (1994) Status epilepticus. A perspective from the neuroscience intensive care unit. Neurosurgery Clinics of North America 5:671-686.
35. Jumao-as A, Brenner RP. (1990) Myoclonic status epilepticus: a clinical and electroencephalographic study. Neurology 40:1199-1202.
36. Kang TM. (2002) Propofol infusion syndrome in critically ill patients. Annals of Pharmacotherapy 36:1453-1456.
37. Kaplan PW. (1999) Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. Journal of Clinical Neurophysiology 16:341-352.
38. Knake S, Rosenow F, Vescovi M, Oertel WH, Mueller HH, Wirbatz A, Katsarou N, Hamer HM, Status Epilepticus Study Group Hessen. (2001) Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 42:714-718.
39. Kofke WA, Young RS, Davis P, Woelfel SK, Gray L, Johnson D, Gelb A, Meeke R, Warner DS, Pearson KS. (1989) Isoflurane for refractory status epilepticus: a clinical series. Anesthesiology 71:653-659.
40. Krishnamurthy KB, Drislane FW. (1999) Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia 40:759-762.
41. Krumholz A, Stern BJ, Weiss HD. (1988) Outcome from coma after cardiopulmonary resuscitation: relation to seizures and myoclonus. Neurology 38:401-405.
42. Krumholz A, Sung GY, Fisher RS, Barry E, Bergey GK, Grattan LM. (1995) Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology 45:1449-1504.
43. Kumar A, Bleck TP. (1992) Intravenous midazolam for the treatment of refractory status epilepticus. Critical Care Medicine 29:483-488.
44. Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B. (1983) Double-blind study of lorazepam and diazepam in status epilepticus. Journal of the American Medical Association 249:1452-1454.
45. Limdi NA, Shimpi AV, Faught E, Gomez CR, Burneo JG. (2005) Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology 64:353-355.
46. Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. (2001) Time trends in incidence, mortality and case-fatality after first episode of status epilepticus. Epilepsia 42:1031-1035.
47. Lothman EW. (1990) The biochemical basis and pathophysiology of status epilepticus. Neurology 40(suppl. 2):13-23.
48. Lowenstein DH. (1999) Status epilepticus: an overview of the clinical problem. Epilepsia 40(suppl. 1):S3-S8.
49. Lowenstein DH, Alldredge BK. (1998) Status epilepticus. New England Journal of Medicine 338:970-976.
50. Lowenstein DH, Bleck T, MacDonald RL. (1999) It's time to revise the definition of status epilepticus. Epilepsia 40:120-122.
51. Martland T, Baxter P, Rittey C. (1998) Is there an agreed treatment for children in status epilepticus? Developmental Medicine and Child Neurology 40:286-287.
52. Mayer SA, Claassen J, Lokin J, Mendelshon F, Dennis LJ, Fitzsimmons BF. (2002) Refractory status epilepticus: frequency, risk factors, and impact on outcome. Archives of Neurology 59:205-210.
53. Maytal J, Novak G, Ascher C, Bienkowski R. (1996) Status epilepticus in children with epilepsy: the role of antiepileptic drug levels in prevention. Pediatrics 98:1119-1121.
54. Milligan NM, Dhillon S, Griffiths A, Oxley J, Richens A. (1984) A clinical trial of single dose rectal and oral administration of diazepam for the prevention of serial seizures in adult epileptic patients. Journal of Neurology, Neurosurgery and Psychiatry 47:235-240.
55. Mirsattari SM, Sharpe MD, Young GB. (2004) Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Archives of Neurology 61:1254-1259.
56. Munn RI, Farrell K. (1993) Failure to recognize status epilepticus in a paralysed patient. The Canadian Journal of Neurological Sciences 20:234-236.
57. Panayiotopoulos CP. (2002) A clinical guide to epileptic syndromes and their treatment. Bladon Medical Publishing, Oxford.
58. Prasad A. Worrall BB, Bertram EH, Bleck TP. (2001) Propofol and midazolam in the treatment of status epilepticus. Epilepsia 42:380-386.
59. Rossetti AO, Reichhart MD, Schaller MD, Despland PA, Bogousslavsky J. (2004) Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia 45:757-763.
60. Scott RC, Besag FM, Neville BG. (1999) Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomized trial. The Lancet 353:623-626.
61. Shaner DM, McCurdy SA, Herring MO, Gabor AJ. (1988) Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology 38:202-207.
62. Shinnar S, Berg AT, Moshe SL, Shinnar R. (2001) How long do new-onset seizures in children last? Annals of Neurology 49:659-664.
63. Shorvon S. (1994) Status epilepticus: its clinical features and treatment in children and adults. Cambridge University Press, Cambridge.
64. Simon RP. (1985) Physiologic consequences of status epilepticus. Epilepsia 26(suppl. 1):S58-S66.
65. Sinha S, Naritoku DK. (2000) Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 55: 722-724.
66. Teng E, Wilkins P. (1994) Lidocaine in status epilepticus. Annals of Pharmacotherapy 28:1248-1249.
67. Theodore WH, Porter RJ, Albert P, Kelley K, Bromfield E, Devinsky O, Sato S. (1994) The secondarily generalised tonic-clonic seizure: a videotape analysis. Neurology 44:1403-1407.
68. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. (1994) Determinants of mortality in status epilepticus. Epilepsia 35:27-34.
69. Treiman DM, Delgado-Escueta AV. (1983) Complex partial status epilepticus. In: Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ (Eds) Status epilepticus: mechanisms of brain damage and treatment, Advances in Neurology, vol. 34. Raven Press, New York, pp. 69-81.
70. Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, Mamdani MB. (1998) A comparison of four treatments for generalised convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. New England Journal of Medicine 339:792-798.
71. Uberall MA, Trollmann R, Wunsiedler U, Wnzel D. (2000) Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology 54:2188-2189.
72. Ulvi H, Yoldas T, Mungen B, Yigiter R. (2002) Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticus. Neurological Sciences 23:177-182.
73. Van Gestel JP, Blussé van Oud-Alblas HJ, Malingre M, Verves FF, Braun KP, van Nieuwenhuizen O. (2005) Propofol and thiopental for refractory status epilepticus in children. Neurology 65:591-592.
74. Vignatelli L, Tonon C, D'Alessandro R, Bologna Group for the Study of Status Epilepticus. (2003) Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia 44:964-968.
75. Walker M. (2005) Status epilepticus: an evidence based guide. British Medical Journal 331:673-677.
76. Walker MC, Smith SJ, Shorvon SD. (1995) The intensive care treatment of convulsive status epilepticus in the UK. Results of a national survey and recommendations. Anesthesia 50:130-135.
77. Walker IA, Slovis CM. (1997) Lidocaine in the treatment of status epilepticus. Academic Emergency Medicine 4:918-922.
78. Walls RM, Sagarin MJ. (1998) Status epilepticus. New England Journal of Medicine 339:409.
79. Young GB, Gilbert JJ, Zochodne DW. (1990) The significance of myoclonic status epilepticus in postanoxic coma. Neurology 40:1843-1848.
80. Young GB, Jordan KG. (1998) Do nonconvulsive seizures damage the brain? - Yes. Archives of Neurology 55:117-119.